Abstract
Introduction As the role of school-aged children was unclear at the onset of the COVID-19 pandemic, public health authorities recommended to implement infection prevention and control (IPC) measures in school settings. Few studies evaluated the implementation of these measures and their effect on SARS-CoV-2 infection rates among pupils and staff.
Aim To describe the implementation of IPC measures in Belgian primary and secondary schools and assess its relation to the prevalence of anti-SARS-CoV-2 antibodies among pupils and staff.
Methods We conducted a prospective cohort study in a representative sample of primary and secondary schools in Belgium. Implementation of IPC measures in schools was assessed using an online questionnaire. Saliva samples were collected from pupils and staff to determine the SARS-CoV-2 seroprevalence.
Results A variety of IPC measures (ventilation, hygiene and physical distancing) was implemented by more than 60% of primary and secondary schools with most attention for hygiene measures. Almost no differences in implementation coverage were observed between primary and secondary schools or the Dutch and French language network. Poor implementation of IPC measures was associated with an increased anti-SARS-CoV-2 antibody prevalence among pupils from 8.6% (95% CI: 4.5 - 16.6) to 16.7% (95% CI: 10.2 - 27.4) and staff from 11.5% (95% CI: 8.1 - 16.4) to 17.6% (95% CI: 11.5 - 27.0). This association was statistically significant for all IPC measures and pupils and staff combined.
Conclusion Belgian schools were relatively compliant with recommended IPC measures at the school level. Poor implementation of IPC measures was associated with higher SARS-CoV-2 seroprevalence among pupils and staff.
Trial registration number Trial registration number: NCT04613817
Competing Interest Statement
The authors have declared no competing interest.
Clinical Protocols
Funding Statement
This study was funded by the Belgian government (COVID-19 SC_044A) through Sciensano, the Belgian institute of Public Health, Brussels, Belgium.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Medical Ethics Committee of the University Hospital Ghent gave ethical approval for this work (reference: B6702020000744 - BC-08564).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
